RXST
Rxsight Inc
NASDAQ: RXST · HEALTHCARE · MEDICAL DEVICES
$6.81
-5.02% today
Updated 2026-04-29
Market cap
$295.88M
P/E ratio
—
P/S ratio
2.20x
EPS (TTM)
$-0.95
Dividend yield
—
52W range
$6 – $17
Volume
0.7M
Rxsight Inc (RXST) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-29.00%
Operating margin
-34.80%
ROE
-14.00%
ROA
-9.56%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $2.24M | $126.22M | -81.17% | -2,055.78% | 5,632.31% |
| 2020 | $14.68M | $27.57M | 11.62% | -241.21% | 187.87% |
| 2021 | $22.59M | $-48.69M | 19.99% | -233.64% | -215.50% |
| 2022 | $49.01M | $-66.76M | 43.52% | -129.21% | -136.22% |
| 2023 | $89.08M | $-48.61M | 60.36% | -56.23% | -54.57% |
| 2024 | $139.93M | $-27.45M | 70.71% | -26.34% | -19.62% |
| 2025 | $134.48M | $-38.94M | 76.60% | -35.84% | -28.96% |